Regulating biotechnology in africa trends and prospects
This presentation is the property of its rightful owner.
Sponsored Links
1 / 29

Regulating Biotechnology in Africa: Trends and Prospects PowerPoint PPT Presentation


  • 89 Views
  • Uploaded on
  • Presentation posted in: General

Regulating Biotechnology in Africa: Trends and Prospects . By Francis Nang’ayo, Ph.D. AATF, Nairobi, Kenya. Outline. Part I Historical milestones The Earth Summit in Rio, Brazil, 1992 Part II Regulatory Landscape in African Countries Policies, Laws, Regulations, Institutions, Projects.

Download Presentation

Regulating Biotechnology in Africa: Trends and Prospects

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Regulating biotechnology in africa trends and prospects

Regulating Biotechnology in Africa:Trends and Prospects

By

Francis Nang’ayo, Ph.D.

AATF, Nairobi, Kenya


Outline

Outline

Part I

  • Historical milestones

  • The Earth Summit in Rio, Brazil, 1992

    Part II

  • Regulatory Landscape in African Countries

  • Policies, Laws, Regulations, Institutions, Projects


Part i regulating gm technology historical perspectives

PART IRegulating GM Technology:Historical Perspectives


Regulating biotechnology in africa trends and prospects

Genetic Modification:

Early Breakthroughs

Regulations for rDNA activities Asilomar Conference, USA

  • Transgenic plants created in early 1980s by four groups working independently:

    • Ghent, Belgium

    • Washington University, St. Louis, USA

    • Monsanto Company in St. Louis, USA

    • University of Wisconsin, USA

NIH Guidelines, 1976

At the conference, scientists raised

concerns about possible adverse

effects of the nascent rDNA research

activities; and voiced the need

to proceed with appropriate safeguards

OECD Ad hoc Expert Group, 1983

Safety focus was on contained

laboratory research and production systems in the US and US-supported projects around the world

Recombinant DNA Safety Considerations,

Published in the ‘Blue Book’ -

the basis for regulation of GMOs in the

Western world


The earth summit

The Earth Summit

  • A landmark conference was held in Rio de Janerio, Brazil, in 1992

  • Focused on Sustainable Development and is associated with following outcomes:

    • Rio Declaration (Principle 15*)

    • Agenda 21 (Chapter 16)

    • UNCBD (The Biosafety Protocol)


Regulating biotechnology in africa trends and prospects

Convention on Biological Diversity

  • Objectives of CBD …are the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of benefits arising out of utilization of genetic resources… via access to genetic resources and by appropriate transfer of relevant technologies …

  • Very simply, the Convention is about access to, transfer of technologies, equitable and sustainable utilization of biodiversity

  • CBD and the Protocol

  • Article 8(g) of the Convention obligates contracting parties to establish means to manage risks associated with use of LMOs resulting from biotechnology …

  • Article 19(3) … need for and modalities of a protocol setting out appropriate procedures … AIA… in the field of safe transfer, handling and use of living modified organisms resulting from biotechnology that may have adverse effect on conservation and sustainable use of biological diversity…”.

Cartagena Protocol on Biosafety about …contributing to ensuring an adequate level of protection in the safe transfer, handling and use of LMOs resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account human health


Cartagena protocol on biosafety

Cartagena Protocol on Biosafety

  • The Protocol is about …contributing to ensuring an adequate level of protection in the safe transfer, handling and use of LMOs resulting from modern biotechnology that may have adverse effects on biological diversity, taking also into account human health …

    • Protocol focuses on transboundary movement of LMOs (…Scope)

    • Advanced Informed Agreement;

    • Premised on the precautionary approach;

    • Socio-economic considerations;

    • Decisions informed by the need to carry out Risk Assessment (Annex III)


Regulating biotechnology in africa trends and prospects

Contracting Parties

Convention on Biological Diversity


Regulating biotechnology in africa trends and prospects

Contracting Parties to Cartagena Protocol on Biosafety


Key obligations of parties to cpb

Key Obligations of Parties to CPB

  • Article 2 (1) … Each Party shall take necessary and appropriate legal, administrative and other measures to implement its obligations…

    A commitment to developing an NBF

    • A Policy on Biotechnology/Biosafety

    • A legislation on biosafety

    • A System for handling requests or notifications

    • A System for monitoring & enforcement

    • Mechanisms for Public Awareness, Education & Participation


Status of nbfs in ssa

Status of NBFs in SSA

  • Countries with developed NBFs,

  • Countries with interim NBFs

  • Countries whose NBF is ‘work-in-progress’

  • Countries with little progress on NBFs.


Regulating biotechnology in africa trends and prospects

Status of GM regulations

Developed National Bio-safety Frameworks

Interim National Bio-safety Frameworks

Work in progress

No significant progress


Regulating biotechnology in africa trends and prospects

Status of GM regulations

Developed National Bio-safety Frameworks

Interim National Bio-safety Frameworks

Work in progress

No significant progress


Wrap up

Wrap up

  • Approaches to regulation for GM crops in Africa has its origins on the outcomes of the Earth Summit:

    • Principle 15 of the Rio Declaration (“Precautionary Approach”)

    • Agenda 21 (Chapter 16)

    • The Convention (CBD)

    • The Protocol (CPB)

  • cf South Africa (SAGENE)


  • Regulations for gm crops in african countries policies laws regulations guidelines

    Regulations for GM crops in African Countries: Policies, Laws, Regulations, Guidelines

    PART II


    Regulating biotechnology in africa trends and prospects

    SUB

    SAHARAN

    AFRICA


    What factors influence policy approaches on gm technology in africa

    Nearly all African countries are contracting parties to the CBD & CPB

    What factors influence Policy Approaches on GM technology in Africa?

    Trade with EU is a major influence on the kind of policytowards GM

    Miami Group

    Vs

    Like-minded Group

    • Concerns regarding threats to Biodiversity

    • Concerns regarding possible loss of markets

    • Regional positions at international forums

    • Novelty surrounding GM technology

    • Food safety scandals and disease epidemics

    • Level of anti-GM activism (NGOs)

    • Challenge of famine, hunger & poverty

    • Reactive “late comer” response approach!

    Mad Cow Disease (BSE); Ebola, Bird Flue


    Policy choices for gm crops

    Policy Choices for GM Crops

    • “Promotional” policy approach

      Assumes GM crops to be as safe as conventional!

    • “Permissive” policy approach

      Approvals made on case-by-case risk assessment considerations e.g. South Africa, Burkina Faso, Kenya, Uganda, etc

    • “Precautionary” policy approach

      Approvals linked to ‘precautionary principle’ e.g. Mauritius, Malawi, Zambia,Tanzania, Ethiopia etc

    • “Preventive” policy approach

      Where GM technology is assumed inherently too risky; e.g. Benin, Angola

      Adapted from Paarlberg (2000)


    Legislation

    Legislation

    • The Protocol , Art 2(1): Each Part shall take necessary and appropriate legal, administrative and other measures to implement its obligations under this Protocol

    • Interpretation

      • Promulgation of new law(s) (e.g. GMO Act, Biosafety Act)

      • Pronouncement of Decrees

      • Use of existing laws through appropriate amendments

    • Merits and demerits


    Legislation1

    Legislation ...

    • Most countries in Sub-Saharan Africa have tended towards developing new laws, thanks to UNEP/GEF program on Biosafety, PBS

    • Developing new laws is a time-consuming process with many “starts and stops” during which time product development may not take place

    • Examples: Kenya; 6 years, Ghana & Nigeria >8 years


    Administrative system

    Administrative System

    • The law is a necessary condition, but alone, it is not a sufficient condition for regulation

    • Thus, laws must be backed by an enabling institutional arrangement for implementation and enforcement (e.g. NBFP, NCA, Biosafety Secretariat*, Agencies, Guidelines, Regulations etc)

    • While some nations have done well in setting Admin. Systems; in most countries of SSA, regulatory institutions still grapple with ‘teething’ problems === thin staff, limited budgets that often delays decision-making!


    Regulating biotechnology in africa trends and prospects

    Pilot Countries


    Summary regulatory landscape

    Summary: Regulatory Landscape


    Regulatory landscape contd

    Regulatory Landscape ...contd


    Regulatory landscape contd1

    Regulatory Landscape ...contd.


    Regulatory landscape contd2

    Regulatory Landscape ...contd.


    Regulating biotechnology in africa trends and prospects

    Wrapping Up!

    Pilot Countries

    NBFs – Functional

    NBFs – Dysfunctional

    NBFs – Work-in-progress


    Paradox of risk assessment

    Paradox of Risk Assessment

    • In ‘the US’ products are safe until proven risky

    • In ‘France’ products are risky until proven safe

    • In ‘India’ products are risky even when proven safe

    • In ‘Canada’ products are neither safe nor risky

    • In ‘Africa’ products are risky even if they do not exist

      Source: Prof CalestousJuma


    Regulating biotechnology in africa trends and prospects

    FONDATION AFRICAINE POUR LES TECHNOLOGIES AGRICOLES

    Thank you for your attention


  • Login